GCY-30215-10170
2 vaccinations
2 coded responses
12 check-ins
2 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 36-40
- ZIP prefix
- 300 / GA
- Registered
- 2022-07-29
- Relationship
- Child or adolescent in my care
- Guardian
- HP6-29237-05125
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-29
Registered in v-safe
-
2022-07-29
Dose 1 — Moderna
-
2022-07-29
Health check-in — day 0, dose 1, dependentFeeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2022-07-30
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-07-31
- 2022-08-02
-
2022-08-03
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Myalgia — Feeling: GoodFree text: Muscle sorenessMedDRA releases: 2024-11 · check-in free text available
- 2022-08-04
- 2022-08-07
- 2022-08-14
- 2022-08-19
-
2022-08-26
Dose 2 — Moderna
-
2022-09-09
Survey response — day 14, dose 2, dependentMedDRA: Cough, Rhinorrhoea — Feeling: GoodFree text: Runny nose. Cough.MedDRA releases: 2024-11 · check-in free text available
- 2022-09-18
- 2022-09-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-29 | Moderna | No |
| 2 | 2022-08-26 | Moderna | No |
Free text
Release 12 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): Muscle soreness
Release 12 — day 14, dose 2, dependent
Symptoms: Runny nose. Cough.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Myalgia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release